SJ
Sanjaykumar Jitendrabhai Jha
About Sanjaykumar Jitendrabhai Jha
Data last updated:
Sanjaykumar Jitendrabhai Jha is a Director at Santis Pharmaceuticals Private Limited (since 2010), Director at Salvavita Pharmaceuticals Private Limited (since 2020) and Director at Cuidado Medico Private Limited (since 2009), and holds 12 more current directorships. The companies operate in Pharma, Trading and Sports. The 11 current companies with reported revenue have a combined latest revenue of ₹28.72 Cr; the largest is Santis Pharmaceuticals Private Limited at ₹13.90 Cr (FY 2021). Earlier, Sanjaykumar Jitendrabhai Jha was a Director at Evinos Pharmaceuticals Private Limited (2022–2023) and Director at Ratnatris Pharmaceuticals Private Limited (2019–2021) and 4 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 19 Apr 2010 | 2010 | ₹13.90 Cr (FY 2021) | Active | |
| Director | 25 Dec 2020 | 2020 | ₹9.64 Cr (FY 2024) | Active | |
| Director | 20 Jan 2009 | 2009 | ₹3.54 Cr (FY 2025) | Active | |
| Director | 11 Mar 2010 | 2010 | ₹77.3 Lakh (FY 2025) | Active | |
| Director | 09 Feb 2011 | 2011 | ₹54.9 Lakh (FY 2024) | Active | |
| Director | 11 May 2007 | 2007 | ₹23.6 Lakh (FY 2017) | Active | |
| Director | 09 Aug 2019 | 2019 | ₹5.5 Lakh (FY 2021) | Active | |
| Director | 31 Mar 2009 | 2009 | ₹1.5 Lakh (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 18 Nov 2022 | 2022 | ₹2.30 Cr (FY 2025) | Active | |
| Director | 31 Jan 2019 | 2005 | ₹142 Cr (FY 2025) | Active | |
| Director | 18 Nov 2009 | 2009 | Strike Off | ||
| Director | 04 Oct 2018 | 2018 | Strike Off | ||
| Director | 28 Mar 2012 | 2012 | Strike Off | ||
| Director | 17 Mar 2017 | 2017 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Sanjaykumar Jitendrabhai Jha
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sanjaykumar Jitendrabhai Jha
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sanjaykumar Jitendrabhai Jha
Sanjaykumar Jitendrabhai Jha currently holds 15 directorships: Santis Pharmaceuticals Private Limited (Director, since 19 Apr 2010, revenue ₹13.90 Cr (FY 2021)); Salvavita Pharmaceuticals Private Limited (Director, since 25 Dec 2020, revenue ₹9.64 Cr (FY 2024)); Cuidado Medico Private Limited (Director, since 20 Jan 2009, revenue ₹3.54 Cr (FY 2025)); Zorway Exim Private Limited (Director, since 11 Mar 2010, revenue ₹77.3 Lakh (FY 2025)); Synergy Pharmasource Private Limited (Director, since 09 Feb 2011, revenue ₹54.9 Lakh (FY 2024)); and 10 more.
Sanjaykumar Jitendrabhai Jha was first appointed on 11 May 2007 as Director at Emzor Exports Private Limited. The most recent appointment on record is 08 Oct 2025 at Injexa Lifesciences Private Limited.
The 11 current companies of Sanjaykumar Jitendrabhai Jha that report revenue have a combined latest revenue of ₹28.72 Cr: Santis Pharmaceuticals Private Limited ₹13.90 Cr (FY 2021); Salvavita Pharmaceuticals Private Limited ₹9.64 Cr (FY 2024); Cuidado Medico Private Limited ₹3.54 Cr (FY 2025); Zorway Exim Private Limited ₹77.3 Lakh (FY 2025); Synergy Pharmasource Private Limited ₹54.9 Lakh (FY 2024); and 6 more.
Sanjaykumar Jitendrabhai Jha held 6 earlier board appointments: Evinos Pharmaceuticals Private Limited (Director, 18 Nov 2022 to 03 Jan 2023); Ratnatris Pharmaceuticals Private Limited (Director, 31 Jan 2019 to 10 Jul 2021); Nosak Healthcare Private Limited (Director, from 18 Nov 2009); Sukarnov Pharmaceuticals Private Limited (Director, from 04 Oct 2018); Miral Pharmaceuticals Private Limited (Director, from 28 Mar 2012); and 1 more.
The current boards of Sanjaykumar Jitendrabhai Jha's companies include Kosha Sanjay Jha (Santis Pharmaceuticals Private Limited), Poonam Samir Desai (Salvavita Pharmaceuticals Private Limited), Jagdishbhai Bhagwatbhai Desai (Cuidado Medico Private Limited), Kartik Nalinbhai Raval (Cuidado Medico Private Limited), Ghanshyam Jitendrabhai Jha (Zorway Exim Private Limited), Hetal Kaushal Shah (Synergy Pharmasource Private Limited), among others.